The company offers software platforms that digitize the clinical trial process, including through EHR integrations.
General Catalyst has been busy lately partnering with several hospitals and health systems on their digital transformations.
“The transformation that we are seeing happen across healthcare has been slow to come to clinical trials,” said Hemant Taneja, Vial board member and CEO and managing director of General Catalyst, in a Nov. 30 Vial news release. “We are thrilled to partner with the Vial team on their mission to reimagine clinical trials.”
The investment brings Vial’s cumulative equity funding to more than $100 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
